Lindbrook Capital, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$4,408
+17.3%
38
+18.8%
0.00%
Q2 2023$3,757
+46.6%
320.0%0.00%
Q1 2023$2,562
-36.6%
32
-37.3%
0.00%
Q4 2022$4,040
+304.0%
51
+410.0%
0.00%
Q3 2022$1,00010
+100.0%
0.00%
Q2 2022$0
-100.0%
5
-58.3%
0.00%
Q1 2022$1,0000.0%12
-52.0%
0.00%
Q1 2020$1,0000.0%25
+31.6%
0.00%
Q4 2019$1,000190.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 2,003,367$232,390,57211.06%
Frazier Life Sciences Management, L.P. 988,460$114,661,3607.62%
S Squared Technology, LLC 108,215$12,552,9406.77%
Avoro Capital Advisors LLC 2,565,555$297,604,3804.64%
APIS CAPITAL ADVISORS, LLC 24,000$2,784,0003.61%
Nicholas Investment Partners, LP 355,611$41,250,8763.08%
Ghost Tree Capital, LLC 80,000$9,280,0003.05%
SILVERARC CAPITAL MANAGEMENT, LLC 71,531$8,297,5962.52%
Affinity Asset Advisors, LLC 57,500$6,670,0001.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 46,092$5,344,8281.80%
View complete list of KRYSTAL BIOTECH INC shareholders